Docoh
Loading...

AXNX Axonics

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM



Axonics, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on June 23, 2021. On April 27, 2021, the record date for determining stockholders entitled to vote at the Annual Meeting, there were 41,902,486 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) outstanding. Holders of 35,617,205 shares of Common Stock (representing 85% of the shares of Common Stock outstanding on the Record Date) were present or represented by proxy at the Annual Meeting, constituting a quorum. During the Annual Meeting, the stockholders of the Company voted on four proposals described in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 30, 2021. The results for each matter voted on by the stockholders during the Annual Meeting were as follows:




Proposal 1: The stockholders of the Company elected Raymond W. Cohen, Robert E. McNamara, Michael H. Carrel, Nancy Snyderman, M.D., FACS, Jane E. Kiernan and David M. Demski to the Board of Directors, each for a one-year term ending at the Annual Meeting of Stockholders to be held in 2022 and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. The results of the stockholders’ vote with respect to the election of the directors were as follows:




NomineeTerm ExpiringForAgainstAbstain
Raymond W. Cohen202231,837,1652,160,61024,073
Robert E. McNamara202222,994,80211,002,83324,213
Michael H. Carrel202222,964,29811,033,54224,008
Nancy Snyderman, M.D., FACS202223,282,32310,715,39224,133
Jane E. Kiernan202233,812,080185,76024,008
David M. Demski202233,991,1566,57824,114





Broker Non-Votes: 1,595,357




Proposal 2: The stockholders of the Company ratified the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021. The results of the stockholders’ vote with respect to such ratification were as follows:




ForAgainstAbstain
35,610,0662,3324,807





Proposal 3: The proposal seeking approval, on an advisory basis, of the compensation of the named executive officers of the Company was approved by the Company’s shareholders, as set forth below:




ForAgainstAbstain
31,371,9792,641,2968,573





Broker Non-Votes: 1,595,357




Proposal 4: The proposal seeking approval, on an advisory basis, of the frequency of future advisory votes on the compensation of the named executive officers of the Company was approved by the Company’s shareholders, as set forth below:




One YearTwo YearsThree YearsAbstain
33,043,0097,410961,9809,449





Broker Non-Votes: 1,595,357